Connect with us

Agricultural Inputs

Sumitomo Chemical India Limited (SUMICHEM) eases after clearing resistance, down 5% intraday

Sumitomo Chemical India Limited (NSE: SUMICHEM) falls 5% intraday, showing pressure after clearing 6M resistance at ₹494. Structural breakout status remains.

abhinav tiwari

Published

on

Sumitomo Chemical India Limited SUMICHEM shows pressure after breakout

Sumitomo Chemical India Limited (SUMICHEM) pulls back after breakout, falling -5% to ₹501.0 on the NSE on 29 Jul 2026. The stock has cleared its 6-month resistance at ₹494.17 but is experiencing a retracement today, likely due to profit-taking. This move is company-specific and does not align with sector momentum, as SUMICHEM operates in the Basic Materials sector under Agricultural Inputs. The recent pullback indicates that while the structural breakout is intact, short-term pressure is present as investors lock in gains.

Technical setup — trendlines & DMA

The current trendline structure shows that SUMICHEM has broken above its 6-month resistance at ₹494.17, with the 6-month support floor at ₹418.67, which is 16.43% below today’s price. The stock is currently trading 1.36% above the resistance level, indicating a breakout. The 50-DMA at ₹481.1 is above the 200-DMA at ₹449.1, signaling a bullish trend. SUMICHEM is 10% above the 50-DMA, suggesting an extended move. The stock is in the middle third of its 52-week range, which implies that a significant portion of the move is already priced in, but there is still room for further gains or corrections.

6M Trendline — Intraday Snapshot
BREAKOUT₹425₹450₹475₹500₹52520 Apr22 May25 Jun29 Jul

Snapshot: ₹501.00 on 2026-07-29 (chart frozen at publication)

Fundamentals & business context

With a PE of 45.6, profit margins of 17.9%, and a revenue CAGR of -2.6%, SUMICHEM appears to be overvalued relative to its current earnings growth. The market may be pricing in a potential turnaround, but the negative revenue CAGR suggests caution. Institutional ownership at 9.2% indicates that smart money is not heavily invested in this name, possibly reflecting concerns about the company’s growth prospects. There is no specific NSE catalyst today that would explain the move, making it likely a result of market dynamics post-breakout.

SUMICHEM
Holdings Analysis
Key strengths & risk signals
54
Overall
50
Fundamental
58
Technical
Risks (4)
OVERVALUED! PEG of 13.42 means expensive relative to growth rate.
POOR YEAR! Stock declined 23.1% in the last year.
WEAK POSITION! Current price (404.8) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.0% (1 week), 10.9% (1 month), 24.8% (3 months).
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
BULLISH TREND! 50-day average (481.1) is above 200-day average (452.8) - positive signal.
OVERSOLD! RSI at 27.8 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.

Algorithmic scorecard

The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for SUMICHEM. The strongest signals are the bullish trend, indicated by the 50-DMA being above the 200-DMA, and the breakout above resistance levels with momentum. These signals suggest that the stock has strong upward momentum and has structurally broken out of a consolidation phase. However, the weakest signals are the declining revenue CAGR of -2.6% and the overvalued PEG of 17.54, which indicate that the stock may be overpriced relative to its growth rate and that revenue growth is lagging. These fundamental weaknesses could pose risks to the stock’s long-term performance.

Fundamental & Technical AnalysisNSE: SUMICHEM
54Overall
50Fundamental
58Technical
Growth Quality7 / 30
Revenue CAGR: -2.6% (DECLINING, 2/15). Profit CAGR: 2.6% (SLOW, 5/15).
Profit Margin6 / 10
GOOD EFFICIENCY! 17.9% profit margin - above average profitability.
PEG Valuation0 / 10
OVERVALUED! PEG of 13.42 means expensive relative to growth rate.
Dividend Yield3 / 10
NEGLIGIBLE DIVIDEND! 0.32% yield - little to no income.
Debt / Equity10 / 10
VERY LOW DEBT! D/E of 0.02 - excellent financial health.
Public Holding16 / 20
LESS PUBLIC HOLDING! 16.96% public ownership - good institutional/promoter control.
Stability8 / 10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Moving Averages12 / 10
BULLISH TREND! 50-day average (481.1) is above 200-day average (452.8) - positive signal.
Price Position2 / 10
WEAK POSITION! Current price (404.8) is below both moving averages.
Trend Pattern10 / 20
TESTING SUPPORT! Stock is at key support level.
52W Performance1 / 10
POOR YEAR! Stock declined 23.1% in the last year.
Volume Sentiment20 / 30
BULLISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 342,724 vs down days: 316,283. Ratio: 1.08x
RSI5 / 5
OVERSOLD! RSI at 27.8 - potential bounce opportunity.
52W Range2 / 5
LOWER HALF! Trading at 20.2% of 52W range - weakness visible.
Momentum1 / 5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.0% (1 week), 10.9% (1 month), 24.8% (3 months).
Beta / Volatility5 / 5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.

Company outlook

Management is cautiously optimistic for FY ’27, driven by the resilience of the Indian agriculture sector and increased minimum support prices. They are entering the fiscal year with production at full capacity and no supply chain constraints. SUMICHEM plans to implement several new capex projects, particularly at the Dahej site, and is in advanced stages of completing techno-commercial feasibility for additional projects. This forward-looking strategy aims to enhance production capabilities and drive growth in the coming year.

Get all details on SUMICHEM — P&L, peers, shareholding and more on TradeAlone.

Agricultural Inputs

Kaveri Seed Company Limited (kscl) Q2 & H1 FY27 Investor Update: Narrower Loss, Export-led Growth

Kaveri Seed Company Limited (KSCL) reports Q2 & H1 FY27 results with narrower net loss, export-led growth, and global expansion.

shalini shishodia tradealone

Published

on

Kaveri Seed Company Limited KSCL Q2 FY27 Results

Kaveri Seed Company Limited (NSE: KSCL) has unveiled its Q2 & H1 FY27 investor update, showcasing a narrower net loss, export-led growth, and significant global expansion. Despite the El Nino impact, the company has maintained cotton volumes and introduced new products in various markets. Notably, the export business surged from ₹12.56 crore to ₹33.07 crore, contributing to a 29.84% year-on-year growth in revenue for Q2 FY27.

H1 FY27 Highlights

The first half of FY27 was shaped by adverse climatic conditions, yet the EBITDA margin held steady at 30.48% compared to 30.32% in H1 FY26. Despite lower revenue, the company maintained its financial health, with a 30.48% EBITDA margin. The maize volumes declined by 36% due to a nearly 30% drop in sowing acreage in Karnataka, but new single-cross hybrids contributed a substantial 21.8% to the maize portfolio.

Q2 FY27 Performance

In Q2 FY27, the company’s net loss significantly narrowed by 41.7% compared to the corresponding quarter of FY26. The standalone revenue grew by 29.84% year-on-year to ₹125.44 crore. The EBITDA rose to ₹5.42 crore, and the net loss was reduced to ₹3.21 crore from ₹15.05 crore in Q2 FY26. The hybrid paddy segment saw substantial growth, driven primarily by the export business, which increased by ~22% compared to the corresponding quarter of the previous year.

Kaveri Seed Company Limited has expanded its global footprint with wholly owned subsidiaries in eight countries, including Tanzania, Kenya, Vietnam, Thailand, Philippines, Indonesia, Zambia, and Peru. The company has also achieved quality accreditations for its QC facility, including ISTA (International Seed Testing Association) and ISO NABL.

As we look forward, Kaveri Seed Company Limited remains committed to its growth trajectory, despite the uncertainties in the agricultural sector. The company’s strategic initiatives and global expansion efforts position it well for future growth and profitability.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Kaveri Seed Company Limited

Kaveri Seed Company Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

KSCL
Basic Materials › Agricultural Inputs
APPROACHING RESISTANCE
56
Fundamental
58
Technical
57
Overall

1W +8.03%
1M +5.89%
3M -13.31%
P/E: 15.2 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Kaveri falls 13.3% over three months and has not found a floor yet. The PEG stands at 5.24 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue grows at 9.2% CAGR. The company generates cash but does not compound aggressively. The stock gains 5.9% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 9.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Kaveri Seed Company Limited.

Continue Reading

Agricultural Inputs

Astec Lifesciences Limited (astec) Q2 FY27: Revenue Down, Ebitda Negative

Astec LifeSciences Limited (ASTEC) reports Q2 FY27 results with a revenue decline and negative EBITDA due to adverse weather and geopolitical uncertainties.

shalini shishodia tradealone

Published

on

Astec Lifesciences Limited ASTEC Q2 FY27 Results

Astec LifeSciences Limited (ASTEC) has announced its financial results for Q2 and H1 of FY27, revealing a challenging performance. The company reported a consolidated total income of ₹72.6 crore in Q2 FY27 compared to ₹74.8 crore in the same period last year, marking a 3% decrease. The consolidated EBITDA stood at (₹19.2 crore) in Q2 FY27 versus (₹5.6 crore) in Q2 FY26, indicating a significant deterioration.

Financial Overview

ASTEC’s consolidated total income for H1 FY27 was ₹156.9 crore, down from ₹166.4 crore in H1 FY26, reflecting a 6% decline. The company’s EBITDA for H1 FY27 was (₹19.1 crore) compared to (₹16.1 crore) in H1 FY26. The reported loss after tax for Q2 FY27 was (₹37.4 crore), up from (₹24.4 crore) in Q2 FY26. For H1 FY27, the loss after tax was (₹56.1 crore) compared to (₹57.4 crore) in H1 FY26.

Impact of Adverse Conditions

Commenting on the performance, Mr. Vishal Sharma, Chairperson of ASTEC, attributed the decline to adverse weather conditions, elevated channel inventories, and cautious procurement by customers. The El Niño impact and poor rainfall in many parts of India have weakened demand. Export sales were further impacted by channel destocking, pricing pressure, and weaker demand in select export markets.

Looking Ahead

ASTEC is focused on expanding its growth platform through enhanced business development efforts and new product introductions. The company aims to improve capacity utilizations, optimize costs, and strengthen operational performance to navigate through the current challenges.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Astec LifeSciences Limited

Astec LifeSciences Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

ASTEC
Basic Materials › Agricultural Inputs
CONSOLIDATING DOWN
26
Fundamental
68
Technical
47
Overall

1W -2.58%
1M +7.33%
3M +2.85%
Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Astec moves sideways over three months, with neither buyers nor sellers taking control. D/E reaches 2.36. High leverage in this environment is a material risk the market cannot ignore. Margins of 15.1% are above average but show signs of plateauing — watch for further pressure. The stock holds at 46% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at -10.8% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Astec LifeSciences Limited.

Continue Reading

Agricultural Inputs

Paradeep Phosphates Limited (paradeep) Signs Mou to Invest ₹4,750 Crore in New Chemical and Fertilizer Facilities

Paradeep Phosphates Limited (PARADEEP) plans to invest ₹4,750 crore in new chemical and fertilizer facilities in Odisha, boosting industrial growth.

priyanka verma tradealone

Published

on

Paradeep Phosphates Limited Paradeep New Chemical and Fertilizer Investment

Paradeep Phosphates Limited (PPL), one of India’s leading fertilizer manufacturers, has signed a Memorandum of Understanding (MoU) with the Government of Odisha to invest ₹4,750 crore in new chemical and fertilizer facilities. This significant investment aims to support industrial growth and employment generation in the state of Odisha.

Strategic Investment

The MoU was signed during India Chem 2026 in Mumbai, in the presence of Hon’ble Chief Minister of Odisha, Shri Mohan Charan Majhi. The proposed investment will support the establishment of a new chemical plant and a bio-fertilizers manufacturing facility, alongside initiatives aimed at enhancing farm productivity.

Government Support

The signing ceremony took place in the presence of Shri Mohan Charan Majhi, Chief Minister, Odisha, along with senior government officials of Odisha. This investment marks a significant step towards strengthening Odisha’s position as a major destination for investments in the chemicals and fertilizers sector. It is also expected to support the expansion of the state’s industrial ecosystem and generate direct and indirect employment across the value chain.

The investment reinforces Paradeep Phosphates’ long-standing association with Odisha and its role in supporting India’s fertilizer requirements. With its established industrial presence in the state, the company continues to contribute to the integration of manufacturing, agriculture, and regional economic development.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Paradeep Phosphates Limited

Paradeep Phosphates Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

PARADEEP
Basic Materials › Agricultural Inputs
CONSOLIDATION
78
Fundamental
60
Technical
70
Overall

1W +0.28%
1M +0.22%
3M +4.92%
P/E: 14.3 Cap: Mid
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Paradeep moves sideways over three months, with neither buyers nor sellers taking control. The PEG of 0.29 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. The stock holds at 58% of its 52-week range with RSI at 44. In other words, neither side has a clear edge right now. Revenue grows at 28.8% and profits at 48.5%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Paradeep Phosphates Limited.

Continue Reading

Trending